MedTrace Logo

Fentanyl Metabolism in Obese Adolescents

NCT01955993 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2013-10-08

No results posted yet for this study

Summary

Fentanyl is a frequently used pain medication in pediatric and adult anesthesia. Although there are some studies considering the breakdown of oral, transmucosal and intravenous fentanyl preparations in children, the disposition of fentanyl in pediatric patients has not been sufficiently described. This study aims to show that the clearance of fentanyl in obese children and adolescents is increased as compared to children with a normal weight. Consequently, the elimination half-life of fentanyl is different in overweight and obese children from that in children having a normal body weight.

Conditions

  • Morbid Obesity

Sponsors & Collaborators

  • Children's National Research Institute

    lead OTHER

Principal Investigators

  • John van den Anker, MD · Children's National Research Institute

Eligibility

Min Age
12 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-01-31
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01955993 on ClinicalTrials.gov